Two-Location Independent Pharmacy Platform - South

NOT DISCLOSED, California

Asking Price	$11,500,000	Year Established	2018
Annual Revenue	$9,951,000	Reason for Selling	Focus on other business
Annual P/L	$0	Attention	Tyler Le
Annual Cash Flow	$0	Listing Number	1015878
# of Employees	13	Business Category	Retail: Health, Beauty, Nutrition

Business Overview:

​$2.17M Adj. EBITDA · Two-Location Pharmacy Platform with 3rd Location Coming

Highly profitable two-location independent retail pharmacy operating in Orange County and San Bernardino County, California. TTM revenue of $9.95M with $2.17M Adjusted EBITDA (21.8% margin) — independently validated by Plante & Moran, PLLC, a top-15 U.S. CPA firm, as part of a formal Quality of Earnings review. +37% YoY Adjusted EBITDA growth.

Both locations are INSIDE medical office buildings — 6 of the top 10 prescribers practice in the SAME building as our pharmacies. Regional hospital is steps away with shared parking (Orange County). Modern VPN-enabled technology stack for multi-store and enterprise management (Leading PMS, Parata robotic dispensing, 2D barcode scanning). Business has implemented an AI Automation bot to process prescriptions 24/7 at a fraction of the labor cost. Owner is not active in day-to-day operations; both Pharmacists-in-Charge are long-tenured and highly likely to remain post-close.

Growth catalysts in flight:
+ Drive-through expansion under construction at a new nearby campus with an urgent care, primary care, PACE center, 150 bed Long-term Care center, and two additional 3-story medical buildings
+ 470+ ALF beds in advanced LTC pipeline discussions
+ Medicare Part B DMEPOS billing infrastructure and Medicare Part B Mass Immunizer active.

Transaction: Structured as a Stock Sale (negotiable) at $11,500,000 listed. Real estate leased at both locations (assumable). 1–6 month flexible transition. Full Plante & Moran QoE workbook released post-IOI. 

*SBA and Lender Pre-Approved.*​

Property Features and Assets:

<p>* Entity: California S-Corporation, 100% owned by a single owner.<br><br>* Location 1 (2018): San Bernardino County opened on the ground floor of a 3-story medical office building.<br><br>* Location 2 (2022): Orange County — opened on the ground floor of a 7-story medical office building; Regional hospital is steps away with shared parking.<br><br>* Operating Model: Decentralized — each site has its own Pharmacist-in-Charge and team, sharing back-office systems (accounting, payroll, wholesaler, PSAO) connected via VPN.<br><br>* Current Initiative: 3-license platform expansion underway (new Drive-Thru retail flagship adds a 3rd pharmacy license; existing pharmacies remain comboshops with dual NPI/NCPDP for retail + LTC). This new location will share the building with an urgent care and primary care physician office.<br><br>* Transaction Structure: Stock Sale (negotiable).</p><p><br></p>

Market Competition and Expansion:

<p>* Chain Retreat Creates Demand: CVS, Walgreens, and Rite Aid have closed 2,000+ U.S. stores since 2023. Well-positioned independents are recapturing displaced demand — particularly in the medical-office-embedded submarkets these pharmacies occupy.<br><br>* Physician-Adjacency Moat: 6 of top 10 prescribers practice in the SAME building as our pharmacies — geographic, sticky, and expensive to replicate in the same submarket.<br><br>*Third-Party QoE (Plante & Moran): QoE-validated financials are rare at this size — materially strengthens buyer confidence and compresses diligence time.<br><br>*Modern Multi-Store Tech Stack: Leading PMS, Parata robotic dispensing, 2D barcode scanning — designed for multi-store enterprise management, VPN-enabled across sites, and includes VOPIX and shared PBX phone system integrated with PMS for click to call, fax, and ability to use vendor apps in case of power outage.<br><br>* AI Automation Bot: 24/7 automated Rx processing at a fraction of human tech labor cost — differentiated cost structure in an industry where labor is the largest opex line.<br><br>* Growing LTC Market: Southern California ALF bed supply is growing faster than LTC pharmacy capacity. Dedicated LTC license pivot addresses undersupplied demand.<br> </p><p><br></p><p>* 3-License Expansion / Drive-Through Flagship: New drive-through retail flagship location under construction — permits pulled, ground broken. Buyer inherits committed CapEx of $120k. This new location will share the building with an urgent care and primary care physician office.<br><br>* New location will share the building with an urgent care and primary care physician office. The same lot will also host two additional 3-story medical office buildings (completed, individual units now selling), a planned PACE program, and a 150-bed assisted living facility opening June 2027—a captive medical campus that drives sustained Rx flow into the new drive-thru.<br><br>* LTC Pipeline (470+ Beds): 470+ ALF beds in advanced discussion — to be serviced by existing comboshop operations (both locations carry dual NPI/NCPDP for retail + LTC). Additionally, currently servicing 4 LTC facilities .<br><br>* AI Automation Bots — Multi-Site Rollout: Bots deployed at both locations and very scalable. Both locations will be able to expand volume without any additional staff.<br><br>* Medicare Part B DMEPOS: Diabetic Supplies (855-S) approved at one location; Immunizations (855-B) active at both sites. Additional DMEPOS categories available.<br><br>* Additional Levers: MTM, RPM, 340B contract pharmacy (with nearby FQHC), expanded immunization outreach, compounding (greenfield), and structured B2B delivery — all documented, none activated.<br> <br></p><p><br></p>

Additional Details: